Skip to content

A Study Protocol for the Validation of UAud in a Clinical Setting.

A Validation of the UAud System for User-operated Audiometry Testing in a Clinical Setting: A Study Protocol for a Blinded Non-inferiority Randomised Controlled Trial.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05043207
Enrollment
250
Registered
2021-09-14
Start date
2022-09-01
Completion date
2024-12-01
Last updated
2023-11-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hearing Impairment, Sensorineural, Hearing Loss, Sensorineural

Brief summary

The objective of this study is to validate the User-operated Audiometry (UAud) system for user-operated audiometry in a clinical setting, by investigating if hearing rehabilitation based on UAud is non-inferior to hearing rehabilitation based on traditional audiometry, and whether thresholds obtained with the user-operated version of the Audible Contrast Threshold (ACT) test correlates to traditional measures of speech intelligibility.

Detailed description

The project will focus on the initial examination of patients who are referred for hearing aid treatment. This initial examination consists of an audiometry which is currently conducted manually by an audiologist. However, it is possible to conduct an audiometry as a user-operated self-test by using a computer. The project will test if hearing rehabilitation based on the user-operated audiometry is non-inferior to hearing rehabilitation based on the gold standard of manual audiometry. The project will use several types of patient reported measures as well as objective measurements in the clinic. Research of this type is needed to understand if the quality of the hearing aid treatment is equal no matter the type of examination. Also, the study will investigate whether thresholds obtained with the user-operated version of the Audible Contrast Threshold (ACT) test correlates to traditional measures of speech intelligibility.

Interventions

DIAGNOSTIC_TESTuAud

Patients will receive hearing aid treatment based on an audiometry obtained with an user-operated automated audiometry procedure

DIAGNOSTIC_TESTTraditional audiometry

Patients will receive hearing aid treatment based on an audiometry obtained with an traditional audiometry procedure

Sponsors

Innovation Fund Denmark
CollaboratorINDIV
William Demant Fonden
CollaboratorUNKNOWN
University of Southern Denmark
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Masking description

The HA fitting procedure will be blinded, so neither the participant, the audiologist, nor the follow up test examiner knows which group the participant belongs to.

Intervention model description

randomised control trial

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Sensorineural hearing loss with hearing thresholds exceeding 20 dB HL at two or more frequencies in the frequency range of 0.5 to 4 kHz. * Symmetric hearing loss with a maximum pure-tone average (PTA) (mean of 0.5-1-2-4 kHz) difference between the ears of 15 dB HL. * Danish native speaker. * No previous experience with HAs. * Capable of answering questionnaires through an online mailbox.

Exclusion criteria

* Air-conduction audiometry thresholds exceeding 80 dB HL at two or more frequencies. * Treatment affected by conductive hearing loss (air-bone gap \>10 dB on more than one frequency below 1 kHz). * Conditions with fluctuating hearing loss, e.g., Menière's, on-going treatment with ototoxic drugs. * Ear, nose, or throat surgery in the past 12 months. * Evidence that the participant has made minor use of the HAs during the study (e.g., \< 2h per day). * Visual or motor impairment that might affect the use of the UAud system.

Design outcomes

Primary

MeasureTime frameDescription
SSQ12 (Speech, Spatial & Qualities of Hearing scale)3 monthsA questionnaire reflecting the patient's subjective assessment of hearing in everyday life.

Secondary

MeasureTime frameDescription
HINT (Hearing In Noise Test)3 monthsA performance test of patients speech intelligibility in noise.

Other

MeasureTime frameDescription
IOI-HA (International Outcome Inventory for Hearing Aids)3 monthsA questionnaire regarding the patient's own perception of hearing aid outcome.
APHAB (Abbreviated Profile of Hearing Aid Benefit).3 monthsA questionnaire regarding the patient's own perception of hearing and hearing aid outcome.
HINT-U (Hearing In Noise test - under amplification)3 months.A variation of the HINT framework targeting potential under amplification of hearing aid sound level.
HINT-O (Hearing In Noise Test - Over amplification)3 months.A variation of the HINT framework targeting potential over amplification of hearing aid sound level.

Countries

Denmark

Contacts

Primary ContactCarl Pedersen, master's degree
pede@sdu.dk+4531314965

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 9, 2026